for people ages up to 30 years (full criteria)
at Oakland, California and other locations
study started
estimated completion:



This study is collecting and storing malignant, borderline malignant neoplasms, and related biological samples from young patients with cancer. Collecting and storing samples of tumor tissue, blood, and bone marrow from patients with cancer to study in the laboratory may help the study of cancer in the future.

Official Title

A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors



  1. Collect malignant, borderline malignant neoplasms, and related biological specimens from Children's Oncology Group institutions for cases in which there is no disease-specific biologic protocol.

II. Provide a repository for long-term storage of malignant, borderline malignant neoplasms, and related biological specimens from these patients.

III. Make specimens available to qualified researchers to understand the biology of cancer in these patients.


Tumor tissue samples, blood, and bone marrow aspirates are collected and stored for future analysis.


Acute Undifferentiated Leukemia Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Childhood Acute Lymphoblastic Leukemia Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Childhood Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Hairy Cell Leukemia Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Neoplasm of Uncertain Malignant Potential Prolymphocytic Leukemia Secondary Acute Myeloid Leukemia T-cell Large Granular Lymphocyte Leukemia Unspecified Childhood Solid Tumor, Protocol Specific Leukemia Neoplasms Leukemia, Myeloid Leukemia, Myeloid, Acute Leukemia, Lymphoid Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Hairy Cell Leukemia, Prolymphocytic Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Leukemia, Myelomonocytic, Juvenile Leukemia, Large Granular Lymphocytic Leukemia, Mast-Cell


For people ages up to 30 years

Inclusion Criteria:

  • Meets any of the following criteria:
  • Diagnosed with primary neoplasm
  • Developed a second malignant neoplasm
  • Any diagnoses having an ICD-O Morphology Code ending in 1, 2, or 3 as listed in the International Classification of Disease for Oncology, Third Edition
  • Must have biological specimens including solid tumors and leukemias available
  • Solid tumors meeting the following criteria:
  • Snap frozen primary tumor OR OCT embedded primary tumor OR formalin fixed(block or tissue in formalin) primary tumor AND at least 10 unstained paraffin slides for NIH Mandated QC (tumors that have undergone central pathology review are allowed)
  • Slides for pathology review (instead of slides for QC) are required for patients with rare tumors
  • Pleural fluid or cytologic specimens meeting the following criteria:
  • At least 1 mL of fluid and at least 2 unstained cytospin slides (or 2 unstained smears)
  • Slides for pathology review (instead of slides for QC) are required for patients with rare tumors
  • 3-6 mL of bone marrow aspirate and 10 mL of whole blood
  • Not eligible for disease-specific biology or banking protocol


  • Children's Hospital and Research Center at Oakland
    Oakland, California, 94609-1809, United States
  • University of California San Francisco Medical Center-Parnassus
    San Francisco, California, 94143, United States
  • Kaiser Permanente-Oakland
    Oakland, California, 94611, United States
  • Children's Hospital Central California
    Madera, California, 93636-8762, United States
  • Lucile Packard Children's Hospital Stanford University
    Palo Alto, California, 94304, United States
  • Children's Hospital Los Angeles
    Los Angeles, California, 90027, United States
  • David Geffen School of Medicine at UCLA
    Los Angeles, California, 90095, United States
  • Mattel Children's Hospital UCLA
    Los Angeles, California, 90095, United States
  • Cedars-Sinai Medical Center
    Los Angeles, California, 90048, United States
  • City of Hope Medical Center
    Duarte, California, 91010, United States
  • Southern California Permanente Medical Group
    Downey, California, 90242, United States
  • Miller Children's Hospital
    Long Beach, California, 90806, United States
  • Childrens Hospital of Orange County
    Orange, California, 92868-3874, United States
  • Loma Linda University Medical Center
    Loma Linda, California, 92354, United States
  • Nevada Cancer Research Foundation CCOP
    Las Vegas, Nevada, 89106, United States


in progress, not accepting new patients
Start Date
Completion Date
Children's Oncology Group
Lead Scientist
Robert Goldsby
Study Type
Last Updated
December 11, 2017